Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Periarticular Injection vs Placebo in ACL Reconstruction
NCT05248724Completed
- Sponsor
- SESCAM
- Start
- Aug 2017
- Primary completion
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine, morphine, ketorolac and epinephrine in postoperative pain (2 arms), sponsored by SESCAM. Primary endpoints: Pain in the knee at 8 hours after surgery, Pain in the knee at 24 hours after surgery and 2 more. Started Aug 2017; status: completed.
02
Drugs
ropivacainemorphineketorolacepinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05248724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05248724.